Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Courtney Tamaki"'
Autor:
Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, Courtney Tamaki, Joshua Fandel, Lingyun Ji, Brent L. Wood, Nirali N. Shah, Constance M. Yuan, Maureen M. O’Brien, Mignon L. Loh, Ernesto Diaz-Flores
Publikováno v:
Blood advances.
Outcomes for pediatric relapsed or refractory acute lymphoblastic leukemia (ALL) remain unsatisfactory. Administration of Inotuzumab ozogamicin (InO), a CD22-targeted antibody-drug conjugate, has shown remarkable activity but predictors of response t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e8f53ac5f73b71689ed563a23f35da6
https://pubmed.ncbi.nlm.nih.gov/35500285
https://pubmed.ncbi.nlm.nih.gov/35500285
Autor:
Stanley Tamaki, Mignon L. Loh, Lingyun Ji, Maureen M. O'Brien, Constance M. Yuan, Josh Fandel, Brent L. Wood, Astrid Wintering, Nirali N. Shah, Kenichi Ishiyama, Courtney Tamaki, Ernesto Diaz-Flores
Publikováno v:
Blood. 138:614-614
Introduction: Despite outstanding cure rates for newly diagnosed patients with acute lymphoblastic leukemia (ALL), outcomes for pediatric patients with relapsed or refractory (R/R) disease remain unsatisfactory. Inotuzumab ozogamicin (InO), a CD22-di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efda492b4b84042cf7a71fbaa5167597
https://doi.org/10.1182/blood-2021-149037
https://doi.org/10.1182/blood-2021-149037